SCHEMBL9765780

SCHEMBL9765780

CC1=C(C(=O)OCCN(C)Cc2ccccc2)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OC(C)C)=C(C)N1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1C Q13936 8/20 0.84
LMNA P02545 5/20 0.84
CYP1A2 P05177 5/20 0.84
CYP3A4 P08684 5/20 0.84
CYP2C9 P11712 5/20 0.84
CYP2C19 P33261 5/20 0.84
CYP2D6 P10635 4/20 0.84
MAPT P10636 4/20 0.84
TSHR P16473 3/20 0.84
TDP1 Q9NUW8 3/20 0.84
ADORA3 P0DMS8 3/20 0.84
ADRA2A P08913 2/20 0.84
NPC1 O15118 1/20 0.84
ABCC4 O15439 1/20 0.84
ABCB11 O95342 1/20 0.84
PGR P06401 1/20 0.84
CHRM2 P08172 1/20 0.84
ABCB1 P08183 1/20 0.84
HTR1A P08908 1/20 0.84
CYP2C8 P10632 1/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11402267 0.99 LMNA (0.85) CACNA1CLMNACYP1A2CYP3A4CYP2C9
SCHEMBL11849741 0.95 CACNA1C (0.77) CACNA1CLMNACYP1A2CYP3A4CYP2C9
Nicardipine SCHEMBL7625913 0.95 CYP1A2 (0.87) CACNA1CLMNACYP1A2CYP3A4CYP2C9
SCHEMBL11845797 0.94 CACNA1C (0.75) CACNA1CLMNACYP1A2CYP3A4CYP2C9
Hydrochloric Acid SCHEMBL10554411 0.94 LMNA (0.93) CACNA1CLMNACYP1A2CYP3A4CYP2C9
Hydrochloric Acid SCHEMBL11835050 0.94 LMNA (0.75) CACNA1CLMNACYP1A2CYP3A4CYP2C9
SCHEMBL9765743 0.92 CACNA1C (0.89) CACNA1CLMNACYP1A2CYP3A4CYP2C9
SCHEMBL11844936 0.92 CACNA1C (0.89) CACNA1CLMNACYP1A2CYP3A4CYP2C9
SCHEMBL8215921 0.92 CACNA1C (0.89) CACNA1CLMNACYP1A2CYP3A4CYP2C9
SCHEMBL10587969 0.92 CACNA1C (0.77) CACNA1CLMNACYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3985758-A 1,4-Dihydropyridine derivatives YAMANOUCHI PHARMACEUTICAL CO., LTD. (JA) 1976-10-12 US claimed
US-4988717-A Optically active 1,4-dihydropyridine esters useful for treating circulatory illnesses BAYER AKTIENGESELLSCHAFT (DE) 1991-01-29 US disclosed
US-4849433-A The compound, (⃡)1,4-dihydro-2,6-dimethyl-4-(2'-nitrophenyl)-pyridine-3,5-dicarboxylic acid, methyl isobutyl ester, compositions containing same and a method for effecting coronary dilation BAYER AKTIENGESELLSCHAFT (DE) 1989-07-18 US disclosed
US-4510310-A 1,4-Dihydro-2,6-dimethyl-4-(2'-chlorophenyl)-3,5-dicarboxylic acid,methyl or ethyl,trifluoroethyl ester BAYER AKTIENGESELLSCHAFT (DE) 1985-04-09 US disclosed
US-3985758-A 1,4-Dihydropyridine derivatives YAMANOUCHI PHARMACEUTICAL CO., LTD. (JA) 1976-10-12 US disclosed